MGM Resorts International (MGM) has an average rating of overweight and mean price target of $45.26, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
Price: $48.57, Change: $+4.90, Percent Change: +11.22%
VeriSign (VRSN) has an average rating of hold and mean price target of $308.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $288.87, Change: $+3.49, Percent Change: +1.22%
Janus Living (JAN) said Monday it launched a public offering of 25 million shares of class A-1 common stock.Underwriters are expected to be granted a 30-day option to purchase up to about 3.8 million additional shares.The senior housing-focused REIT said it plans to use the net proceeds to pursue acquisition and investment opportunities that meet its criteria, as well as for general corporate purposes.Shares of the company fell more than 4% in recent premarket activity Monday.Price: $25.54, Change: $-1.23, Percent Change: -4.59%
Invivyd (IVVD) said Monday that it has completed patient enrolment in the phase 3 Declaration trial, evaluating its VYD2311 antibody for the prevention of symptomatic COVID-19.Top-line results from the study are still expected in late Q3, the company said.The Declaration study is evaluating the prevention of symptomatic COVID-19 at three months, with either a single dose or monthly doses of VYD2311, administered via intramuscular injection, compared to placebo, Invivyd said.Shares of the company were up 2.6% in Monday's premarket activity.Price: $1.17, Change: $+0.03, Percent Change: +2.63%